Florian max*
Cancer biomarkers have emerged as valuable tools in the diagnosis and treatment of cancer. These molecular or cellular indicators provide information about the presence, stage, and aggressiveness of a tumour, and can also help monitor treatment response and predict outcomes. Biomarkers can be detected in various types of samples, including blood, urine, and tissue specimens, and can be measured using a range of technologies, from simple assays to advanced genomic profiling techniques. In recent years, significant progress has been made in identifying and validating new biomarkers for different cancer types, and several of these have already been incorporated into clinical practice.
English 
Spanish 
Chinese 
Russian 
German 
French 
Portuguese 
Hindi